N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancer. Superficial bladder ...

TUR is both diagnostic and therapeutic, and findings or outcomes can dictate further disease management. Restaging TUR in patients with T1 tumors is an important component of management. Intravesical ...

When a doctor suspects bladder cancer, they will order a series of tests which may include urine tests (urinalysis or urine ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

“You have cancer.” Few words carry more weight. For people diagnosed with non–muscle invasive bladder cancer (NMIBC), advances in the field can be encouraging; yet, even amid innovation and ongoing ...